Clinical Trials in Baltimore

Showing 12061-12080 of 20,142 trials

Answer ALS: Individualized Initiative for ALS Discovery

NCT02574390

Creation of a large repository of induced pluripotent stem cells (iPSC), bio-fluid samples (blood and spinal fluid (optional)), and cell lines for ALS gene identification. This will be combined carefully with collected measures of the pattern of the symptoms people with ALS have and how these change over time. People with other motor neuron diseases and healthy controls will be included as comparisons

Amyotrophic Lateral SclerosisPrimary Lateral SclerosisFlail Arm ALS+5 more

Johns Hopkins University1,049 participantsStarted Dec 2015

Los Angeles, California, United States • Atlanta, Georgia, United States • Chicago, Illinois, United States +5 more locations

TERMINATEDPhase 3< 1 mile

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes

NCT02556203

To assess whether a rivaroxaban-based anticoagulation strategy, following successful TAVR, compared to an antiplatelet-based strategy, is superior in reducing death or first thromboembolic events (DTE). To assess the primary bleeding events (PBE) of the rivaroxaban-based strategy compared to an antiplatelet-based strategy, following TAVR.

Transcatheter Aortic Valve Replacement

Bayer1,653 participantsStarted Dec 2015

Los Angeles, California, United States • Washington D.C., District of Columbia, United States • Clearwater, Florida, United States +137 more locations

Answer ALS: Individualized Initiative for ALS Discovery

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes

Find Trials by Condition in Baltimore

Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of ACT-1004-1239 in Healthy Male Subjects

Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee

A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness

Von Hippel-Lindau Disease Genetic Epidemiology Study

HIV Accelerated Liver Disease in Uganda

A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

Study to Evaluate DNL201 in Subjects With Parkinson's Disease

Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder

A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients

Safety and Tolerability of TAR-302-5018 in Subjects With Neurogenic Detrusor Overactivity Resulting From Spinal Cord Injury

Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade

Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer

COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal Gel

Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia